{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:36:57Z","timestamp":1773308217618,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.schres.2007.04.027","type":"journal-article","created":{"date-parts":[[2007,6,16]],"date-time":"2007-06-16T14:11:18Z","timestamp":1182003078000},"page":"293-305","source":"Crossref","is-referenced-by-count":33,"title":["FDG-PET in never-previously medicated psychotic adolescents treated with olanzapine or haloperidol"],"prefix":"10.1016","volume":"94","author":[{"given":"Monte S.","family":"Buchsbaum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Mehmet","family":"Haznedar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Aronowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam M.","family":"Brickman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall E.","family":"Newmark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse","family":"Brand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim E","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desmond","family":"Heath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan","family":"Starson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin A.","family":"Hazlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2007.04.027_bib1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archpsyc.1992.01820080023004","article-title":"The Comprehensive Assessment of Symptoms and History (CASH): An instrument for assessing diagnosis and psychopathology","volume":"49","author":"Andreasen","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2007.04.027_bib2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/archpsyc.1992.01820120031006","article-title":"Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London","volume":"49","author":"Andreasen","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2007.04.027_bib3","series-title":"Digital Processing of Biomedical Imagery","first-page":"101","article-title":"Significance probability mappings and automated interpretation of complex pictorial scenes","author":"Bartels","year":"1976"},{"key":"10.1016\/j.schres.2007.04.027_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0925-4927(91)90003-9","article-title":"Importance of pharmacologic control in PET studies: effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia","volume":"40","author":"Bartlett","year":"1991","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.schres.2007.04.027_bib5","first-page":"95","article-title":"Regional cerebral blood flow changes associated with risperidone treatment in elderly schizophrenia patients: a pilot study","volume":"32","author":"Berman","year":"1996","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.schres.2007.04.027_bib6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/oxfordjournals.schbul.a033331","article-title":"Positron emission tomography studies of abnormal glucose metabolism in schizophrenia","volume":"24","author":"Buchsbaum","year":"1998","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2007.04.027_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000093342","article-title":"Positron emission tomography imaging of Risperidone augmentation in SRI-refractory patients","volume":"53","author":"Buchsbaum","year":"2006","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.schres.2007.04.027_bib8","first-page":"155","article-title":"Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia","volume":"6","author":"Buchsbaum","year":"1992","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2007.04.027_bib9","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1001\/archpsyc.1992.01820120054008","article-title":"Striatal metabolic rate and clinical response to neuroleptics in schizophrenia","volume":"49","author":"Buchsbaum","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2007.04.027_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0447.1999.tb05992.x","article-title":"Visualizing fronto-striatal circuitry and neuroleptic effects in schizophrenia","volume":"395","author":"Buchsbaum","year":"1999","journal-title":"Acta Psychiatr. Scand., Suppl."},{"key":"10.1016\/j.schres.2007.04.027_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S1461145701002280","article-title":"Effect of fluoxetine on regional cerebral metabolism in autistic spectrum disorders: a pilot study","volume":"4","author":"Buchsbaum","year":"2001","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2007.04.027_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0920-9964(01)00361-9","article-title":"Differential metabolic rates in prefrontal and temporal Brodmann areas in schizophrenia and schizotypal personality disorder","volume":"54","author":"Buchsbaum","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2007.04.027_bib13","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.schres.2006.03.042","article-title":"D2\/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia","volume":"85","author":"Buchsbaum","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2007.04.027_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000093342","article-title":"Positron emission tomography imaging of risperidone augmentation in serotonin reuptake inhibitor-refractory patients","volume":"53","author":"Buchsbaum","year":"2006","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.schres.2007.04.027_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine","volume":"14","author":"Bymaster","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2007.04.027_bib16","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archpsyc.1997.01830170107014","article-title":"The brain metabolic patterns of clozapine-and fluphenazine-treated patients with schizophrenia during a continuous performance task","volume":"54","author":"Cohen","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2007.04.027_bib17","series-title":"The California Verbal Learning Test","author":"Delis","year":"1987"},{"key":"10.1016\/j.schres.2007.04.027_bib18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0925-4927(02)00124-5","article-title":"Cerebral metabolic patterns in chronic and recent-onset schizophrenia","volume":"122","author":"Desco","year":"2003","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.schres.2007.04.027_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0022-3565(24)39197-9","article-title":"Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism","volume":"293","author":"Duncan","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.schres.2007.04.027_bib20","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1124\/jpet.102.048140","article-title":"Chronic administration of haloperidol and olanzapine attenuates ketamine-induced brain metabolic activation","volume":"305","author":"Duncan","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.schres.2007.04.027_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pscychresns.2006.04.002","article-title":"Abnormal glucose metabolism in the anterior cingulate cortex in patients with schizophrenia","volume":"154","author":"Fujimoto","year":"2007","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.schres.2007.04.027_bib22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0197-4580(98)00075-X","article-title":"Age-related shift in brain region allocation during successful memory performance","volume":"19","author":"Hazlett","year":"1998","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.schres.2007.04.027_bib23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/1469-8986.3520186","article-title":"Prefrontal cortex glucose metabolism and startle eyeblink modification abnormalities in unmedicated schizophrenia patients","volume":"35","author":"Hazlett","year":"1998","journal-title":"Psychophysiology"},{"key":"10.1016\/j.schres.2007.04.027_bib24","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1176\/ajp.156.8.1190","article-title":"Three-dimensional analysis with MRI and PET of the size, shape, and function of the thalamus in the schizophrenia spectrum","volume":"156","author":"Hazlett","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2007.04.027_bib25","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00004583-200007000-00010","article-title":"Review of neuroimaging studies of child and adolescent psychiatric disorders from the past 10\u00a0years","volume":"39","author":"Hendren","year":"2000","journal-title":"J. Am. Acad. Child Adolesc. Psych."},{"key":"10.1016\/j.schres.2007.04.027_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pscychresns.2005.10.004","article-title":"Striatal dopamine D1 and D2 receptor balance in twins at increased genetic risk for schizophrenia","volume":"146","author":"Hirvonen","year":"2006","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.schres.2007.04.027_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1176\/ajp.153.1.41","article-title":"Functional sites of neuroleptic drug action in the human brain: PET\/FDG studies with and without haloperidol","volume":"153","author":"Holcomb","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2007.04.027_bib28","doi-asserted-by":"crossref","first-page":"13432","DOI":"10.1073\/pnas.96.23.13432","article-title":"Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia","volume":"96","author":"Honey","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.schres.2007.04.027_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-0447.1974.tb09707.x","article-title":"Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia","volume":"50","author":"Ingvar","year":"1974","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2007.04.027_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0925-4927(97)00050-4","article-title":"Cerebral glucose metabolism in childhood onset schizophrenia","volume":"75","author":"Jacobsen","year":"1997","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.schres.2007.04.027_bib31","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0006-3223(02)01602-5","article-title":"Functional effects of antipsychotic drugs: comparing clozapine with haloperidol","volume":"53","author":"Lahti","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2007.04.027_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pscychresns.2005.02.006","article-title":"Functional effects of single dose first-and second-generation antipsychotic administration in subjects with schizophrenia","volume":"139","author":"Lahti","year":"2005","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.schres.2007.04.027_bib33","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0006-3223(00)01001-5","article-title":"Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia","volume":"49","author":"Miller","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2007.04.027_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(02)00199-8","article-title":"Cerebral metabolism and risperidone treatment in schizophrenia","volume":"60","author":"Molina","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2007.04.027_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0925-4927(03)00107-0","article-title":"Anatomical and functional cerebral variables associated with basal symptoms but not risperidone response in minimally treated schizophrenia","volume":"124","author":"Molina","year":"2003","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.schres.2007.04.027_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00004850-200501000-00003","article-title":"Olanzapine-induced cerebral metabolic changes related to symptom improvement in schizophrenia","volume":"20","author":"Molina","year":"2005","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2007.04.027_bib37","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/jnnp.72.1.106","article-title":"Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naive schizophrenic patients: correlations with symptom change","volume":"72","author":"Ngan","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.schres.2007.04.027_bib38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0006-3223(93)90288-O","article-title":"Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients","volume":"33","author":"Nordstrom","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2007.04.027_bib39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.psychres.2004.04.002","article-title":"Modulating sensorimotor gating in healthy volunteers: the effects of desipramine and haloperidol","volume":"127","author":"Oranje","year":"2004","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2007.04.027_bib40","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0306-4522(98)00465-5","article-title":"Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine","volume":"90","author":"Piggott","year":"1999","journal-title":"Neuroscience"},{"issue":"Suppl B","key":"10.1016\/j.schres.2007.04.027_bib41","first-page":"63","article-title":"Clozapine effects on glucose metabolic rate in striatum and frontal cortex","volume":"55","author":"Potkin","year":"1994","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2007.04.027_bib42","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.neuroimage.2004.03.004","article-title":"Gradients of dopamine D1-and D2\/3-binding sites in the basal ganglia of pig and monkey measured by PET","volume":"22","author":"Rosa-Neto","year":"2004","journal-title":"NeuroImage"},{"key":"10.1016\/j.schres.2007.04.027_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(01)00163-3","article-title":"A review of MRI findings in schizophrenia","volume":"49","author":"Shenton","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2007.04.027_bib44","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/archpsyc.55.3.235","article-title":"Dorsal striatal size, shape, and metabolic rate in neuroleptic-naive and previously medicated schizophrenic patients performing a verbal learning task","volume":"55","author":"Shihabuddin","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2007.04.027_bib45","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/archpsyc.58.9.877","article-title":"Striatal size and relative glucose metabolic rate in schizotypal personality disorder and schizophrenia","volume":"58","author":"Shihabuddin","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2007.04.027_bib46","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1176\/appi.ajp.157.11.1782","article-title":"Feeling unreal: a PET study of depersonalization disorder","volume":"157","author":"Simeon","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2007.04.027_bib47","unstructured":"StatSoft, I., 2003. Statistica. Tulsa, OK: www.statsoft.com."},{"key":"10.1016\/j.schres.2007.04.027_bib48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000026471","article-title":"Greater metabolic rate decreases in hippocampal formation and proisocortex than in neocortex in Alzheimer's disease","volume":"37","author":"Stein","year":"1998","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.schres.2007.04.027_bib49","series-title":"Co-planar Stereotaxic Atlas of the Human Brain","author":"Talairach","year":"1988"},{"key":"10.1016\/j.schres.2007.04.027_bib50","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1017\/S1461145703003699","article-title":"Decreased thalamic D2\/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457","volume":"6","author":"Talvik","year":"2003","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2007.04.027_bib51","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pscychresns.2006.05.009","article-title":"Dopamine D2 receptor binding in drug-naive patients with schizophrenia examined with raclopride-C11 and positron emission tomography","volume":"148","author":"Talvik","year":"2006","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.schres.2007.04.027_bib52","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1176\/appi.ajp.158.12.2015","article-title":"Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex","volume":"158","author":"Volkow","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2007.04.027_bib53","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00004728-199307000-00004","article-title":"MRI-PET registration with automated algorithm","volume":"17","author":"Woods","year":"1993","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.schres.2007.04.027_bib54","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0920-9964(02)00230-X","article-title":"Comparative analysis of acute and chronic administration of haloperidol and clozapine using [3H] 2-deoxyglucose metabolic mapping","volume":"61","author":"Wotanis","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2007.04.027_bib55","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1176\/appi.ajp.161.6.1016","article-title":"Low dopamine D2 receptor binding in subregions of the thalamus in schizophrenia","volume":"161","author":"Yasuno","year":"2004","journal-title":"Am. J. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996407001715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996407001715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T08:09:34Z","timestamp":1737101374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996407001715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":55,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0920996407001715"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2007.04.027","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}